IndraLab

Statements


| 32

reach
"Spinocerebellar ataxia type 3 (SCA3) is caused by an expanded polyglutamine stretch in ataxin-3."

reach
"For example, SCA3 is caused by abnormal expansion of the polyglutamine in the C-term region of the protein, and the cleavage of the C-term fragment by caspases has been suggested to be essential for pathology of the disease XREF_BIBR."

reach
"Machado-Joseph disease (MJD, also known as spinocerebellar ataxia type 3, SCA3), an autosomal dominant neurological disorder, is caused by an abnormal expanded polyglutamine (polyQ) repeat in the ataxin-3 protein."

reach
"Hsp104 Suppresses Polyglutamine Induced Degeneration Post Onset in a Drosophila MJD and SCA3 Model."

reach
"The deubiquitinating enzyme Ataxin-3 (ATXN3) contains a polyglutamine (PolyQ) region, the expansion of which causes spinocerebellar ataxia type-3 (SCA3)."

reach
"Spinocerebellar ataxia type 3 (SCA3), the most common spinocerebellar ataxia, is caused by a polyglutamine (polyQ) expansion in the protein ataxin-3 (ATXN3)."

reach
"A polyglutamine expansion mutation in ataxin-3 causes spinocerebellar ataxia type 3 (SCA3), thereby providing a further link between ubiquitin dependent protein quality control mechanisms and neurodegeneration XREF_BIBR, XREF_BIBR."

reach
"Spinocerebellar ataxia (also called Machado-Joseph disease) is a late-onset neurodegenerative disease caused by the expansion of polyglutamine (CAG) repeats in the MJD1 gene."

reach
"SCA1, SCA2, MJD and SCA3, SCA6, SCA, and SCA17 are caused by polyglutamine encoding CAG repeat expansions."

reach
"Spinocerebellar ataxia type 3 (SCA3, also known as Machado-Joseph disease), a hereditary neurodegenerative disease, is caused by an abnormal expansion of the polyglutamine tract in the causative ATXN3 protein."

reach
"Treatment with this compound enhanced degradation of proteins important in neurodegeneration such as tau, TDP43 or ataxin-3 (a polyglutamine expanded protein causing SCA3), and could provide novel strategies for increasing protein degradation by regulating protein degradation by the UPS."

reach
"SCA3 is caused by an expanded polyglutamine tract in the ataxin-3 protein, resulting in conformational changes that lead to toxic gain of function."

reach
"SCA2 and SCA3 are caused by polyglutamine expansions in ataxin2 and ataxin3, respectively [XREF_BIBR, XREF_BIBR]."

reach
"Spinocerebellar ataxia 3 (SCA3), a neurodegenerative disease characterized mainly by progressive ataxia affecting balance, gait and speech, is caused by a mutation in the C-terminus polyglutamine (PolyQ) region of the ataxin-3 protein, an ubiquitously expressed deubiquitinating enzyme with important functions in the proteasomal protein degradation pathway and regulation of transcription."

reach
"SCA3 is caused by an expanded polyglutamine tract in the ataxin-3 protein, resulting in conformational changes that lead to toxic gain of function."

reach
"Machado-Joseph disease (MJD), the most common dominantly inherited ataxia worldwide, is caused by a polyglutamine (polyQ) expansion in the deubiquitinating (DUB) enzyme ataxin-3."

reach
"Hsp104 suppresses polyglutamine induced degeneration post onset in a drosophila MJD and SCA3 model."

reach
"Six of the most frequent dominantly inherited spinocerebellar ataxias (SCAs) worldwide - SCA1, SCA2, SCA3, SCA6, SCA7, and SCA17 - are caused by an expansion of a polyglutamine (polyQ) tract in the corresponding proteins."

reach
"Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), is autosomal dominant neurodegenerative disease caused by an expansion of polyglutamine encoding CAG repeats in the ATXN3 gene."

reach
"Spinocerebellar ataxia type 3 (SCA3) is caused by a CAG and polyglutamine repeat expansion in the SCA3 gene."

reach
"Additionally, it is well acknowledged that the pathogenesis of SCA3 and MJD is involved with pathogenic ataxin-3 induced by expanded polyglutamine repeat in ATXN3."

reach
"Machado-Joseph disease (MJD) or Spinocerebellar Ataxia type 3 is caused by a polyglutamine encoding CAG expansion in the ATXN3 gene, which encodes a 42 kDa deubiquitinating enzyme (DUB), ataxin-3."

reach
"More studies are required to develop therapeutic agents for treating spinocerebellar ataxia type 3 (SCA3), which is caused by mutant polyglutamine expanded ataxin-3 and is the most prevalent subtype of spinocerebellar ataxias."

reach
"Decreased ataxin-3 cleavage may result in decreased formation of neurotoxic ataxin-3 protein aggregates, through decreased presence of the lone aggregation prone polyglutamine containing peptide."
| PMC

reach
"Finally, we link this novel function of ataxin-3 to molecular events that may contribute to SCA3 disease pathogenesis : polyglutamine expansion increases the affinity of ataxin-3 for CHIP, which correlates with decreased levels of this neuroprotective E3 in a mouse model of SCA3."

reach
"A peptide inhibitor of polyglutamine aggregation, known as polyQ binding peptide 1, has been shown previously to prevent the maturation of ataxin-3 fibrils."

reach
"SCA3 is caused by polyglutamine expansion in ataxin-3."

reach
"Spinocerebellar ataxia type 3 (SCA3), or Machado-Joseph disease (MJD), is caused by the expansion of a polyglutamine repeat in the ataxin-3 protein."

reach
"The ATXN3 targeting ASO achieved sustained reduction of polyglutamine expanded ATXN3 up to 8 weeks after treatment and prevented oligomeric and nuclear accumulation of ATXN3 up to at least 14 weeks after treatment."

reach
"For example, spinocerebellar ataxia type 3 (SCA3), which is characterized by progressive dysfunction of the cerebellum and brain stem, is caused by polyglutamine (polyQ) expansion in the ataxin-3 gene."

reach
"SCA3 is caused by a polyglutamine encoding CAG repeat expansion in the ATXN3 gene."

reach
"SCA3 is caused by polyglutamine expansion of the Ataxin-3 gene and is the most common inherited cerebellar ataxia in some populations [XREF_BIBR]."